Lipoproteins, Human Plasma, Very Low Density recombinant protein
VLDL
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P98155 |
---|---|
Calculated MW | 10.0-80,000.0 kDa |
Gene ID | 7436 |
---|---|
Gene Symbol | VLDLR |
Other Names | VLDL |
Source | Human plasma |
Assay&Purity | SDS-PAGE; ≥95% |
Assay2&Purity2 | HPLC; ≥95% |
Recombinant | No |
Format | Liquid |
Storage | +4°C; Liquid in 150 mM NaCl, pH 7.4, and 0.01% EDTA |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
In a normal fasting individual, VLDL concentrations range from 0.5 - 2.0 g/L. VLDL transports triglycerides synthesized by the liver to sites of energy storage and utilization.
References
Gafvels M.E.,et al.Somat. Cell Mol. Genet. 19:557-569(1993).
Webb J.C.,et al.Hum. Mol. Genet. 3:531-537(1994).
Sakai J.,et al.J. Biol. Chem. 269:2173-2182(1994).
Oka K.,et al.Genomics 20:298-300(1994).
Humphray S.J.,et al.Nature 429:369-374(2004).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.